1. Home
  2. SEAT vs XBIT Comparison

SEAT vs XBIT Comparison

Compare SEAT & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivid Seats Inc.

SEAT

Vivid Seats Inc.

BUY

Current Price

$2.72

Market Cap

79.0M

Sector

Industrials

ML Signal

BUY

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$1.93

Market Cap

69.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SEAT
XBIT
Founded
2001
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Pharmaceuticals and Biotechnology
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
79.0M
69.8M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
SEAT
XBIT
Price
$2.72
$1.93
Analyst Decision
Buy
Analyst Count
9
0
Target Price
★ $11.68
N/A
AVG Volume (30 Days)
★ 71.4K
53.2K
Earning Date
11-05-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.82
$30.47
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$2.74
$1.91
52 Week High
$13.87
$3.44

Technical Indicators

Market Signals
Indicator
SEAT
XBIT
Relative Strength Index (RSI) 25.52 25.20
Support Level N/A N/A
Resistance Level $7.68 $2.42
Average True Range (ATR) 0.24 0.09
MACD 0.06 -0.03
Stochastic Oscillator 0.00 10.64

Price Performance

Historical Comparison
SEAT
XBIT

About SEAT Vivid Seats Inc.

Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry, providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada, and Japan. It operates in two segments: Marketplace, which generates maximum revenue, and Resale. The Marketplace segment acts as an intermediary between ticket buyers, sellers, and partners, earning revenue from processing ticket sales for live events and facilitating the booking of hotel rooms and packages on websites and mobile applications. The Resale segment acquires tickets to resell on secondary ticket marketplaces, including its own, and offers internal research and development support for Skybox.

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

Share on Social Networks: